# CHERAMI

> CHERAMI is a VC fund in Guangzhou backing Medical and Health Care. See 15 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Guangzhou, China
- Total investments: 15
- Last investment: Mar 2026
- Lead investor: 33%
- Last updated: Aug 2026
- Website: http://www.ifc-cherami.com/

CHERAMI is a private equity fund management firm.

## Contacts

5 contacts available for CHERAMI. Shizune tracks 1 team members at CHERAMI. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cherami?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 27% |
| Health Care | 3 | 20% |
| Biotechnology | 3 | 20% |
| Artificial Intelligence | 3 | 20% |
| Pharmaceutical | 2 | 13% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 33% |
| Series B | 2 | 13% |
| Series D | 1 | 7% |
| Venture - Series Unknown | 1 | 7% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 8 | 53% |
| United States | 1 | 7% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Yin Li | Investment Director | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| UniX AI | UniX AI possesses advanced research and development capabilities in the domain of embodied intelligent robotics. The team comprises specialists from various disciplines, including structural engineering, electronics, algorithms, and deep learning. This technology company focuses on enhancing the robot's ability to generalize in intricatescenarios. | $43.7M | Venture - Series Unknown | Mar 02, 2026 |  |
| ProteLight Pharmaceuticals | ProteLight Pharmaceuticals engages in the development and production of antimicrobial peptide drugs and chemical drugs. |  | Series D | Jan 04, 2026 |  |
| NeuShen Therapeutics | NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders. |  | Series A | Apr 18, 2025 |  |
| MoleculeMind | MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform. | $14M | Series A | Sep 13, 2024 |  |
| ICleague Technology | ICleague Technology to satisfy situations requiring high processing power, high bandwidth, and low power consumption. |  | Series B | Jul 17, 2024 |  |
| EPICMEMS | Kaiyuan Communication Technology (Xiamen) Co., Ltd. is an local chip company focusing on RF front-end solutions. The company is headquartered in Haicang District, Xiamen City, and currently has an operation center in Zhangjiang, Shanghai, and sales and customer support centers in Shenzhen, Xi'an and Beijing. |  | Series B | Jan 05, 2024 |  |
| Enkang Pharmaceutical Technology | Enkang Pharmaceutical Technology develops innovative new anti-cancer drugs and pharmaceutical products. Enkang Pharmaceutical Technology is committed to the research and development of original small molecules and nucleic acid anti-cancer drugs targeting DNA replication initiation proteins (DRIPs) and has applied for domestic and foreign inventionpatents. |  | Series B | Jan 23, 2023 |  |
| Hyzon Motors | Hyzon is a global supplier of hydrogen fuel cell-powered commercial vehicles, including heavy duty trucks, buses and coaches. |  | Post-IPO Equity | Jan 01, 2023 |  |
| PVmed | PVmed focuses on AI-enhanced auxiliary diagnosis and treatment. The company was founded in 2017 and is headquartered in Guangzhou, China. | $14M | Series A | Dec 22, 2022 |  |
| First Technology | First Technology is a projection display technology enterprise with original technology and core patent capabilities. It covers the entire industry chain from product design, mold development, production, and manufacturing. | $15M | Series C | Jun 02, 2022 |  |

10 of 15 investments shown.

## Co-investors
- [Westlake Village BioPartners](https://shizune.co/investors/profile/westlake-village-biopartners) — VC Fund, 2 deals together
- [Winzac Capital](https://shizune.co/investors/profile/winzac-capital) — VC Fund, 2 deals together
- [Bank of China Group Investment](https://shizune.co/investors/profile/bank-of-china-group-investment) — VC Fund, 1 deal together
- CDHTI Venture Capital — VC Fund, 1 deal together
- [CICC](https://shizune.co/investors/profile/cicc) — VC Fund, 1 deal together
- CITIC Limited — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does CHERAMI invest in?

CHERAMI invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 15 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact CHERAMI?

Public channels for CHERAMI include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at CHERAMI?

The team at CHERAMI includes Yin Li (Investment Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co